UK markets closed
  • FTSE 100

    +8.52 (+0.11%)
  • FTSE 250

    -248.86 (-1.24%)
  • AIM

    -4.39 (-0.47%)

    -0.0047 (-0.40%)

    -0.0110 (-0.92%)

    -1,692.43 (-8.51%)
  • CMC Crypto 200

    -30.18 (-5.57%)
  • S&P 500

    -54.31 (-1.27%)
  • DOW

    -253.81 (-0.75%)

    +0.59 (+0.65%)

    -7.80 (-0.44%)
  • NIKKEI 225

    -11.77 (-0.04%)

    +9.12 (+0.05%)
  • DAX

    -152.89 (-1.12%)
  • CAC 40

    -61.57 (-0.94%)

Geriatric Medicines Market Report Up to 2031: Visiongain Research Inc

·5-min read

Visiongain has published a new report on Geriatric Medicines Market Report 2021-2031: Forecasts By Therapeutic Category (Analgesic, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitor, Anticoagulant, Antipsychotic and Antidepressant, and Others), By Condition (Cardiovascular, Arthritis, Diabetes, Neurological, Cancer, Osteoporosis, Respiratory, and Others) By Drug Type (Generic Drugs, and Branded Drugs), By Form (Tablet, Capsules, Ointment, Gel, Lotion, Others), By Route of Administration (Oral, Topical, Intravenous, Others), By Mode of Prescription (OTC, and Prescribed), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @

COVID-19 Impact on Geriatric Medicines Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Geriatric Medicines market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:

Market Drivers

Increasing Geriatric Population around the World
Geriatric population is increasing very fast around the world from last few decades. All regions are facing a huge increase in the number of geriatric population. For instance: According to United Nations, Department of Economic and Social Affairs, Population Division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Geriatric population are at high risk of developing chronic diseases due to decreased immune system. Rapid increase in number of the geriatric population around the globe is also increase demand for geriatric medicines around the world. Due to which increasing geriatric population around the world is working as a driver for the geriatric medicines market.

Availability of Reimbursement in Developing Nations

Demand for geriatric medicines is increasing very rapidly due to availability of reimbursement in developing nations. Reimbursement from governments and private insurance players has increase significantly increasing for elderly care which is increasing diagnosis and treatment rate in geriatric population and which is also increasing demand of geriatric medicines for treatment of various chronic diseases in geriatric population. Increasing demand of geriatric medicines is leading several of the manufacturers to launch their product portfolios in geriatric medicines due to this reason the factor is working as a driver for the geriatric medicines market.

Market Opportunities

Government Initiative and Awareness Program
Various governments, international organization, regulatory authorities, independent authority, non-profit organizations is launching various awareness program across the developed & developing countries to increase awareness regarding availability of diagnosis and treatment for geriatric population. Increasing government initiative and awareness program is expected to increase demand of elderly care drugs and expected to create various new opportunities for geriatric medicines market

Get Detailed TOC @

Competitive Landscape

Top companies (Pfizer, Inc., Merck & Co., Inc., and AstraZeneca) constitute more than XX% share of the global Geriatric Medicines market. Other companies profiled in the report include: Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Abbott Laboratories, Boehringer Ingelheim GmbH among) others Some of the key developments are listed below:

  • In 2017, Sanofi has received The U.S. Food and Drug Administration (FDA) approval for Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients. The launch will help company widened revenue generation from market focused product portfolio.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the geriatric medicines market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Therapeutic Drug Sector click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.


Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Follow Us: LinkedIn | Twitter


SOURCE Visiongain Limited.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting